Peter Richardson

Peter Richardson

Directeur Technique/Scientifique/R&D chez MALLINCKRODT PLC

64 ans
Health Technology
Consumer Services

Profil

Peter C.
Richardson
is currently the Chief Scientific Officer & Executive VP at Mallinckrodt Plc and a Member of The Royal College of Physicians.
Previously, he was the Chief Medical Officer & Executive VP-Research at Antares Pharma, Inc. from 2021 to 2022, the Chief Scientific Officer & Vice President at MannKind Corp.
from 2005 to 2012, the Senior VP & Global Head-Development Alliance at Novartis Pharmaceuticals Corp.
from 1991 to 2005, and the Senior Vice President & Head-Development at Novartis Pharma KK from 2003 to 2005.
He also served as the Chief Medical Officer at Adare Pharma Solutions, Inc. from 2016 to 2020.
Richardson received his undergraduate and doctorate degrees from The University of Nottingham.

Postes actifs de Peter Richardson

SociétésPosteDébut
MALLINCKRODT PLC Directeur Technique/Scientifique/R&D 12/01/2023
The Royal College of Physicians Corporate Officer/Principal -
Tous les postes actifs de Peter Richardson

Anciens postes connus de Peter Richardson

SociétésPosteFin
ANTARES PHARMA, INC. Directeur Technique/Scientifique/R&D 24/05/2022
President 01/01/2016
MANNKIND CORPORATION Directeur Technique/Scientifique/R&D 01/01/2012
Corporate Officer/Principal 01/10/2005
Corporate Officer/Principal 01/01/2005
Voir l'expérience en détail de Peter Richardson

Formation de Peter Richardson

The University of Nottingham Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Peter Richardson

Relations

100 +

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
MANNKIND CORPORATION

Health Technology

MALLINCKRODT PLC

Health Technology

Entreprise privées4

Health Technology

Health Technology

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Peter Richardson